Anhco Nguyen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anhco nguyen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anhco Nguyen Today - Breaking & Trending Today

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Average Recommendation of "Hold" from Analysts

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have earned an average recommendation of “Hold” from the three analysts that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation. The average 1 year price target among brokers that have updated their coverage on the […] ....

United States , Pascal Touchon , Anhco Nguyen , Atara Biotherapeutics Inc , Pricet Rowe Associates Inc , Staley Capital Advisers Inc , Capital Management , Securities Exchange Commission , Redmile Group , Acadian Asset Management , Get Free Report , Marketbeat Ratings , Exchange Commission , Asset Management , Staley Capital Advisers , Capital Advisers , Get Free ,

Atara Biotherapeutics (NASDAQ:ATRA) Given Neutral Rating at HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. HC Wainwright also issued estimates for Atara Biotherapeutics’ Q2 2024 earnings at $0.06 EPS, Q3 2024 earnings at ($0.28) EPS, Q4 2024 earnings at ($0.28) EPS, FY2024 earnings […] ....

United States , Anhco Nguyen , Pascal Touchon , Harbor Capital Advisors Inc , Atara Biotherapeutics Inc , Vontobel Holding Ltd , Advisor Group , Josh Arnold Investment Consultant , Atara Biotherapeutics Company Profile , Delap Wealth Advisory , Free Report , Get Free Report , Wealth Advisory , Arnold Investment Consultant , Harbor Capital Advisors , Capital Advisors ,

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Expected to Post Q1 2025 Earnings of ($0.27) Per Share

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Atara Biotherapeutics in a research note issued on Wednesday, May 22nd. HC Wainwright analyst R. Burns expects that the biotechnology company will post earnings of ($0.27) per share for the quarter. […] ....

United States , Anhco Nguyen , Pascal Touchon , Advisor Group , Atara Biotherapeutics Company Profile , Securities Exchange Commission , Harbor Capital Advisors Inc , Delap Wealth Advisory , Vontobel Holding Ltd , Atara Biotherapeutics Inc , Free Report , Get Free Report , Exchange Commission , Wealth Advisory , Capital Advisors , Financial Markets ,

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) EVP Sells $26,597.38 in Stock

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) EVP Anhco Nguyen sold 42,899 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $0.62, for a total transaction of $26,597.38. Following the sale, the executive vice president now owns 898,498 shares of the company’s […] ....

United States , Anhco Nguyen , Capital Management , Redmile Group , Acadian Asset Management , Pricet Rowe Associates Inc , Staley Capital Advisers Inc , Atara Biotherapeutics Inc , Get Free Report , Asset Management , Staley Capital Advisers , Capital Advisers ,